Lord Glenarthur's office asked for a "fairly full draft letter" to respond to a parliamentary question asked by Baroness Masham. The draft response from the Department included the note that "we have confirmed with American manufacturers that future supplies of Factor VIII for this country will be manufactured only from plasma collected in accordance with US Food and Drug Administration Regulations introduced in March this year".

Chronology Information

Date:

Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Major Lord Simon Mark Glenarthur